OncoHealth Gets $1.6M For Cervical Cancer Testing
Redwood City-based OncoHealth, a developer of tests for cervical cancer and other cancers caused by human papillomavirus (HPV) viruses, has raised $1.6M in a Series A investment, the firm said today. The funding included Sand Hill Angels, Band of Angels, Emergent Medical Partners, Halo Fund, Tech Coast Angels, The Angels Forum, and Wilmington Investor Network. As part of the funding, Don Ross of the Sand Hill Angels and Life Science Angels has joined the firm's board.
posted on Tuesday, May 3, 2011 (Link to more information)
Related companies:
OncoHealth
Related stories:
> Veracyte Gets $28M
> Grail Gets $300M More For Cancer Detection Testing
> Color Genomics Captures $45M For Genetic Testing For Cancer Risk
> DiaCarta Gets $8M For Molecular Diagnostics
> Counsyl Gets $28M For Genetic Testing Service
silicontap.com Home